University of Sydney spin-out company Medsaic has developed a proprietary technology, DotScan, which can be used to diagnose haematological malignancies, solid tissue tumours and autoimmune diseases

A new biotechnology incubator facility due to open in Queensland by the end of this year is calling for companies seeking mentoring and support. [ + ]

Cochlear boss Chris Roberts has spent 30 years at Australia's leading device companies -- but that doesn't mean he has stopped learning, as Helen Schuller discovers. [ + ]

Dump the drugs? No -- but dump the stigma of 'biotech' and look for proper recognition from the investment community, writes CogState CEO Peter Bick. [ + ]

You may be strapped for time, but a poorly-chosen new recruit could set you back even further, writes Jeremy Wurm. [ + ]

If your brain disengages when you read the word 'ethics', perhaps you'd better switch it on again, writes Iain Scott -- there's a lot you haven't heard on the subject. [ + ]

In an outcome recalling one of Australia's greatest scientific achievements, researchers from the CRC for Clean Power from Lignite (CRC CPL) have designed and commercialised a revolutionary instrument

A University at Buffalo scientist created a stir in 2003 when he announced a much faster, more precise and far less expensive method of obtaining nuclear magnetic resonance (NMR) data to map a protein's atomic structure

Ann Uldridge explains the reasoning behind a new group for women in the biotechnology industry. [ + ]

Scientists, industry and government are doing their bit to develop the Australian biotechnology industry, writes Peter Andrews -- so where are the investors? [ + ]

Australian Biotechnology News editor-in-chief Iain Scott spoke with renowned industry analyst Cynthia Robbins-Roth about what it will take to keep biotech alive. [ + ]

A team of scientists, led by researchers at The University of Nottingham, is studying the secret sex life of a fungus that causes potentially life-threatening infections in an effort to find new ways of controlling the disease

Growth of certain adherent cell lines can be problematic due to poor attachment to traditional tissue culture treated surfaces. This article demonstrates the use of the Corning CellBind Surface to improve the recovery and yield of LNCaP cells

Nature can assemble complex structures in a single step so why can't we? Well we can, if we know enough about supramolecular chemistry and bring together the right ingredients

Researchers at the Australian Research Council Centre of Excellence in Biotechnology and Development, are rapidly gaining ground on the mysteries of male infertility and progressing the development of a reversible male contraceptive